title: Current advances in Phellinus sensu lato: medicinal species, functions, metabolites and mechanisms.
abstract: Twenty-six species of Phellinus sensu lato, reported as medicinal mushrooms, are enumerated in this review. The species' names were checked and revised according to contemporary taxonomy and the latest version of the International Code of Botanical Nomenclature (Vienna Code); two misapplied names of Phellinus baumii Pilát and Phellinus himalayensis Y.C. Dai in previous reports are also discussed. Of the 20 types of medicinal functions, the most shared functions are antitumor and improving immunity, both of which may be viewed as the basal functions of Phellinus s. l. In addition, alleviating septic shock, anti-inflammatory, and antioxidation are also a routine functions mentioned often. The main medicinal metabolites, including several kinds of polysaccharides and polyphenols, are introduced. Different methods and conditions could purify various polysaccharides with difference in activity level even from the same species, while all polyphenols are hispidin and its derivatives in general. Three aspects of mechanism contribute to antitumor activities of polysaccharides: (1) promoting an immune response, (2) inducing cell apoptosis, and (3) inhibiting metastasis. Other general mechanisms of the metabolites in antioxidant activity, and in treating diabetes, as well as complications are summarized. We also elaborate on potential scientific strategies for obtaining the medicinal metabolites from Phellinus s. l., such as artificial cultivation, the discoveries of more species with medicinal functions, the utilization of species growing quickly, and the optimization of culture conditions and media supplements in fermentation.
authors.affiliation: Institute of Microbiology, Beijing Forestry University, PO Box 61, Beijing 100083, China. yuchengd@yahoo.com
authors.forename: Yu-Cheng
authors.initials: YC
authors.lastname: Dai
authors.forename: Li-Wei
authors.initials: LW
authors.lastname: Zhou
authors.forename: Bao-Kai
authors.initials: BK
authors.lastname: Cui
authors.forename: Yan-Qiu
authors.initials: YQ
authors.lastname: Chen
authors.forename: Cony
authors.initials: C
authors.lastname: Decock
mesh_terms: D000893:Anti-Inflammatory Agents / Q000302:isolation & purification / Q000378:metabolism; D000970:Antineoplastic Agents / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology; D000975:Antioxidants / Q000302:isolation & purification / Q000378:metabolism; D001487:Basidiomycota / Q000145:classification* / Q000378:metabolism*; D005419:Flavonoids / Q000302:isolation & purification / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000302:isolation & purification / Q000378:metabolism; D007155:Immunologic Factors / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology; D010636:Phenols / Q000302:isolation & purification / Q000378:metabolism; D059808:Polyphenols; D011134:Polysaccharides / Q000302:isolation & purification / Q000378:metabolism
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000975:Antioxidants; D005419:Flavonoids; D007004:Hypoglycemic Agents; D007155:Immunologic Factors; D010636:Phenols; D059808:Polyphenols; D011134:Polysaccharides